Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI
Edward A. Copelan, Betty K. Hamilton, Belinda Avalos, Kwang W. Ahn, Brian J. Bolwell, Xiaochun Zhu, Mahmoud Aljurf, Koen Van Besien, Christopher Bredeson, Jean Yves Cahn, Luciano J. Costa, Marcos De Lima, Robert P. Gale, Gregory A. Hale, Joerg Halter, Mehdi Hamadani, Yoshihiro Inamoto, Rammurti T. Kamble, Mark R. Litzow, Alison W. LorenDavid I. Marks, Eduardo Olavarria, Vivek Roy, Mitchell Sabloff, Bipin N. Savani, Matthew Seftel, Harry C. Schouten, Celalettin Ustun, Edmund K. Waller, Daniel J. Weisdorf, Baldeep Wirk, Mary M. Horowitz, Mukta Arora, Jeff Szer, Jorge Cortes, Matt E. Kalaycio, Richard T. Maziarz, Wael Saber
Dive into the research topics of 'Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI'. Together they form a unique fingerprint.